Connect With Us:
REPORT ID 3973

Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017

Publish Date
14-Dec-17
Pages
116
Format
Electronic (PDF)

Full report description 
This report studies Non-Insulin Therapies for Diabetes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    GSK
    Eli Lilly
    Sumitomo Dainippon Pharma
    Intarcia Therapeutics
    Servier
    Jiangsu Hansoh Pharmaceutical
    Novo Nordisk
    Emisphere
    Uni-Bio Science Group
    Takeda
    3SBio
    Merck
    Dong-A Pharmaceutical
    Luye Pharma Group
    Eurofarma
    Geropharm
    Alkem Labs
    SatRx
    Pfizer
    Jiangsu Hengrui Medicine

By types, the market can be split into
    Alpha-glucosidase Inhibitors
    Amylin Agonists
    Biguanides
    Dipeptidyl Peptidase-4 (DPP4) Inhibitors
    Glinides / Meglitinides
    GLP-1 Analogs / GLP-1 Agonists
    Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
    Sulfonylureas
    Thiazolidinediones
    Others

By Application, the market can be split into
    Hospital Pharmacy
    Retail Pharmacies
    Online Pharmacy
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of contents 
Table of Contents

Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017
1 Industry Overview of Non-Insulin Therapies for Diabetes
    1.1 Definition and Specifications of Non-Insulin Therapies for Diabetes
        1.1.1 Definition of Non-Insulin Therapies for Diabetes
        1.1.2 Specifications of Non-Insulin Therapies for Diabetes
    1.2 Classification of Non-Insulin Therapies for Diabetes
        1.2.1 Alpha-glucosidase Inhibitors
        1.2.2 Amylin Agonists
        1.2.3 Biguanides
        1.2.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
        1.2.5 Glinides / Meglitinides
        1.2.6 GLP-1 Analogs / GLP-1 Agonists
        1.2.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
        1.2.8 Sulfonylureas
        1.2.9 Thiazolidinediones
        1.2.10 Others
    1.3 Applications of Non-Insulin Therapies for Diabetes
        1.3.1 Hospital Pharmacy
        1.3.2 Retail Pharmacies
        1.3.3 Online Pharmacy
        1.3.4 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes
    2.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
    2.4 Industry Chain Structure of Non-Insulin Therapies for Diabetes

3 Technical Data and Manufacturing Plants Analysis of Non-Insulin Therapies for Diabetes
    3.1 Capacity and Commercial Production Date of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016

4 Global Non-Insulin Therapies for Diabetes Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Non-Insulin Therapies for Diabetes Capacity and Growth Rate Analysis
        4.2.2 2016 Non-Insulin Therapies for Diabetes Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Non-Insulin Therapies for Diabetes Sales and Growth Rate Analysis
        4.3.2 2016 Non-Insulin Therapies for Diabetes Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Non-Insulin Therapies for Diabetes Sales Price
        4.4.2 2016 Non-Insulin Therapies for Diabetes Sales Price Analysis (Company Segment)

5 Non-Insulin Therapies for Diabetes Regional Market Analysis
    5.1 North America Non-Insulin Therapies for Diabetes Market Analysis
        5.1.1 North America Non-Insulin Therapies for Diabetes Market Overview
        5.1.2 North America 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
        5.1.4 North America 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
    5.2 China Non-Insulin Therapies for Diabetes Market Analysis
        5.2.1 China Non-Insulin Therapies for Diabetes Market Overview
        5.2.2 China 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
        5.2.4 China 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
    5.3 Europe Non-Insulin Therapies for Diabetes Market Analysis
        5.3.1 Europe Non-Insulin Therapies for Diabetes Market Overview
        5.3.2 Europe 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
        5.3.4 Europe 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
    5.4 Southeast Asia Non-Insulin Therapies for Diabetes Market Analysis
        5.4.1 Southeast Asia Non-Insulin Therapies for Diabetes Market Overview
        5.4.2 Southeast Asia 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
        5.4.4 Southeast Asia 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
    5.5 Japan Non-Insulin Therapies for Diabetes Market Analysis
        5.5.1 Japan Non-Insulin Therapies for Diabetes Market Overview
        5.5.2 Japan 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
        5.5.4 Japan 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
    5.6 India Non-Insulin Therapies for Diabetes Market Analysis
        5.6.1 India Non-Insulin Therapies for Diabetes Market Overview
        5.6.2 India 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
        5.6.4 India 2016 Non-Insulin Therapies for Diabetes Market Share Analysis

6 Global 2012-2017E Non-Insulin Therapies for Diabetes Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Non-Insulin Therapies for Diabetes Sales by Type
    6.2 Different Types of Non-Insulin Therapies for Diabetes Product Interview Price Analysis
    6.3 Different Types of Non-Insulin Therapies for Diabetes Product Driving Factors Analysis
        6.3.1 Alpha-glucosidase Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.2 Amylin Agonists of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.3 Biguanides of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.5 Glinides / Meglitinides of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.6 GLP-1 Analogs / GLP-1 Agonists of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.8 Sulfonylureas of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.9 Thiazolidinediones of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        6.3.10 Others of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis

7 Global 2012-2017E Non-Insulin Therapies for Diabetes Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Non-Insulin Therapies for Diabetes Consumption by Application
    7.2 Different Application of Non-Insulin Therapies for Diabetes Product Interview Price Analysis
    7.3 Different Application of Non-Insulin Therapies for Diabetes Product Driving Factors Analysis
        7.3.1 Hospital Pharmacy of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        7.3.2 Retail Pharmacies of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        7.3.3 Online Pharmacy of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
        7.3.4 Others of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Non-Insulin Therapies for Diabetes
    8.1 GSK
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 GSK 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 GSK 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.2 Eli Lilly
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Eli Lilly 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Eli Lilly 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.3 Sumitomo Dainippon Pharma
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Sumitomo Dainippon Pharma 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Sumitomo Dainippon Pharma 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.4 Intarcia Therapeutics
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Intarcia Therapeutics 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Intarcia Therapeutics 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.5 Servier
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Servier 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Servier 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.6 Jiangsu Hansoh Pharmaceutical
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Jiangsu Hansoh Pharmaceutical 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Jiangsu Hansoh Pharmaceutical 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.7 Novo Nordisk
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Novo Nordisk 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Novo Nordisk 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.8 Emisphere
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Emisphere 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Emisphere 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.9 Uni-Bio Science Group
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Uni-Bio Science Group 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Uni-Bio Science Group 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.10 Takeda
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Takeda 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Takeda 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
    8.11 3SBio
    8.12 Merck
    8.13 Dong-A Pharmaceutical
    8.14 Luye Pharma Group
    8.15 Eurofarma
    8.16 Geropharm
    8.17 Alkem Labs
    8.18 SatRx
    8.19 Pfizer
    8.20 Jiangsu Hengrui Medicine

9 Development Trend of Analysis of Non-Insulin Therapies for Diabetes Market
    9.1 Global Non-Insulin Therapies for Diabetes Market Trend Analysis
        9.1.1 Global 2017-2022 Non-Insulin Therapies for Diabetes Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Non-Insulin Therapies for Diabetes Sales Price Forecast
    9.2 Non-Insulin Therapies for Diabetes Regional Market Trend
        9.2.1 North America 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
        9.2.2 China 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
        9.2.3 Europe 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
        9.2.5 Japan 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
        9.2.6 India 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
    9.3 Non-Insulin Therapies for Diabetes Market Trend (Product Type)
    9.4 Non-Insulin Therapies for Diabetes Market Trend (Application)

10 Non-Insulin Therapies for Diabetes Marketing Type Analysis
    10.1 Non-Insulin Therapies for Diabetes Regional Marketing Type Analysis
    10.2 Non-Insulin Therapies for Diabetes International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Non-Insulin Therapies for Diabetes by Region
    10.4 Non-Insulin Therapies for Diabetes Supply Chain Analysis

11 Consumers Analysis of Non-Insulin Therapies for Diabetes
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    ?

12 Conclusion of the Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source